Hydrogen bonds in the crystal packings of mesalazine and mesalazine hydrochloride

Dedicated to Prof. George Zundel on the occasion of his 65th birthday.
https://doi.org/10.1016/S0022-2860(97)00043-4Get rights and content

Abstract

The crystal structures of pharmaceutical product mesalazine (marketed also under different proprietary names as Salofalk, Asacol, Asacolitin, and Claversal) and its hydrochloride are reported. In the crystal mesalazine is in zwitterion form as 5-ammoniosalicylate (1) whereas mesalazine hydrochloride crystallizes in an ionized form as 5-ammoniosalicylium chloride (2). Compound 1 (C7H7O3N) crystallizes in the monoclinic space group P21n with a = 3.769(1) Å, b = 7.353(2) Å, c = 23.475(5) Å, β = 94.38(2)°, V = 648.7(8) Å3, Z = 4, Dc = 1.568 g cm−3 and μ(MoKα) = 1.2 cm−1. Compound 2 (C7H8O3NCl) crystallizes in the triclinic space group P 1̄ with a = 4.4839(2) Å, b = 5.7936(2) Å, c = 15.6819(5) Å, α = 81.329(3)°, β = 88.026(3)°, γ = 79.317(4)°, V = 395.74(3) Å3, Z = 2, Dc = 1.591 g cm−3 and μ(CuKα) = 40.8 cm−1. The crystal structures were solved by direct methods and refined to R = 0.041 for 1 and 0.028 for 2, using 607 and 1374 observed reflections, respectively. The configuration of both molecules, with the ortho hydroxyl to a carboxyl group, favours the intramolecular hydrogen bonds. Very complex systems of intermolecular hydrogen bonds were observed in both crystal packings. They are discussed in terms of graph-set notation. The mesalazine crystal structure is characterized by two-dimensional network of hydrogen bonds in the ab plane. The crystal structure pattern of mesalazine hydrochloride is a three-dimensional network significantly supported by N+H⋯Cl interactions.

References (13)

  • L.S. Goodman et al.

    The Pharmacological Basis of Therapeutics

  • Cambridge Structural Database System

    (1996)
  • A.L. Spek

    Helena

  • G.M. Sheldrick
  • G.M. Sheldrick

    Shelxl 93

  • A.L. Spek
There are more references available in the full text version of this article.

Cited by (0)

View full text